Navigation Links
Cell Biosciences Announces New Leadership
Date:6/25/2008

PALO ALTO, Calif., June 25 /PRNewswire/ -- Cell Biosciences, Inc., a provider of ultrasensitive protein detection and characterization systems to life science researchers, today announced three important additions to its management team.

Tim Harkness was named President and Chief Executive Officer. From 1998 through 2007, Mr. Harkness was the Chief Financial Officer for Molecular Devices Corporation where he helped build the company into a global leader in life science research tools with over $185 million in revenue before successfully selling the company in 2007. Mr. Harkness brings deep knowledge of worldwide life sciences markets, and is expected to lead the transformation of Cell Biosciences into a mature commercial operation.

Richard Lussier was named Vice President, Sales and International Operations. Mr. Lussier has more than 20 years experience in life science sales and commercial operations, including 13 years in the Applera businesses Applied Biosystems and Celera Genomics. During his tenure at Applera, he served as President and General Manager of their Japanese subsidiary for five years. More recently, Mr. Lussier established the worldwide sales, service, and support organization for Solexa Inc., now part of Illumina Inc.

Also announced was the appointment of Walter Ausserer, Ph.D. as Vice President, Marketing. Dr. Ausserer has more than 15 years experience in the development, sales, and marketing of bioanalytical instrumentation. Most recently, he directed product development at Axela Biosensors, a developer of label-free protein characterization systems. Dr. Ausserer previously held senior product development and marketing positions at Caliper Life Sciences and Dionex Corporation.

"The Cell Biosciences team has developed a truly revolutionary technology for protein characterization that I believe has the potential to significantly impact many areas of biological research," said Mr. Harkness. "I am impressed by the tremendous potential of the Cell Biosciences team and technology, and am very excited about the opportunity to lead the company."

The management team appointments come on the heels of multiple recent placements of the Firefly(TM) 3000 system, Cell Bioscience's flagship product for ultrasensitive detection and characterization of proteins in extremely small biological samples. Cell Biosciences began accepting orders for the Firefly 3000 system in late 2007 as part of an early technology access program for leading cell signaling and translational medicine researchers. Participants in the program receive early access to the Firefly 3000 system, which provides unprecedented levels of sensitivity for the analysis of precious samples, such as tissue biopsies, fine-needle tumor aspirates, and stem cells.

To fuel its commercial expansion, the company closed a Series B financing round of $27 million in late 2006, with participation from the Wellcome Trust, Domain Associates, Latterell Venture Partners, Novo Ventures, Posco BioVentures, Mitsui & Co. Venture Partners, RBC Capital Partners and The Vertical Group.

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nano-proteomics. We are developing instrumentation systems to enable the detection of specific proteins in extremely small biological samples. The company's lead product, the Firefly 3000, is a capillary-based nanofluidic immunoassay platform designed for ultrasensitive detection and characterization of proteins. Cell Biosciences is located in Palo Alto, CA. http://www.cellbiosciences.com

For additional information, please contact Walter Ausserer, Vice President, Marketing, Cell Biosciences, Inc. 650 859-1485.


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL
2. LI-COR(R) Biosciences Introduces New Tools for High Throughput Western Blotting
3. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
4. LI-COR Biosciences Introduces Near-Infrared Small Animal Imager
5. Craig Johnson Joins Ardea Biosciences Board of Directors
6. Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
7. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
8. LI-COR(R) Biosciences and Tiger Woods Learning Center Collaborate to Develop High School Curriculum in Genetics
9. YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING
10. Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
11. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... Weeks after hosting a carpal tunnel syndrome workshop with ... surgeon and founder of the Fitzmaurice Hand Institute, has announced the addition of MRI ... state-of-the-art technology and only 1 of about 3 currently available in the United States. ...
(Date:5/27/2016)... ... ... Doctors in Italy, Japan, the UK and the US have reached some surprising ... its link to malignant mesothelioma. Surviving Mesothelioma has just posted the details of their ... , The studies analyzed for the new report included more than 3,447 cancer patients. ...
(Date:5/27/2016)... At present, the Biotech sphere is in a ... volatility is what makes this industry interesting to consider. Here ... (NASDAQ: SNTA ), CTI BioPharma Corp. (NASDAQ: ... and Heat Biologics Inc. (NASDAQ: HTBX ). Sign ... these stocks at: http://www.activewallst.com/register/ ...
(Date:5/26/2016)... New Jersey and READING, ... Indegene ( http://www.indegene.com ), a leading ... to life science, pharmaceutical and healthcare organisations and ... of innovative scientific support throughout the product lifecycle, ... with the launch of IntraScience.      ...
Breaking Biology Technology:
(Date:3/22/2016)... PROVO and SANDY, Utah ... (NSO), which operates the highest sample volume laboratory in ... Tute Genomics and UNIConnect, leaders in clinical sequencing informatics ... the launch of a project to establish the informatics ... NSO has been contracted by the ...
(Date:3/18/2016)... 18, 2016 --> ... ICT, Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance ... in the border security market and the continuing migration crisis ... Europe has led visiongain to publish this ... --> defence & security companies in the ...
(Date:3/15/2016)... ALBANY, New York , March 15, 2016 ... a new market report published by Transparency Market Research "Digital ... Growth, Trends and Forecast 2015 - 2023," the global digital ... at US$ 731.9 Mn in 2014 and is forecast to ... to 2023. Growth of micro, small and medium enterprises (MSMEs) ...
Breaking Biology News(10 mins):